Latest p/e ratio
Halozyme Therapeutics P/E ratio
Direct answer
Halozyme Therapeutics's p/e ratio is 36.1x.
The verified market snapshot reports 36.1x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- P/E ratio
- 36.1x
Explore related company data
View Halozyme Therapeutics's market capitalizationView Halozyme Therapeutics's price-to-book ratioView Halozyme Therapeutics's return on equityView Halozyme Therapeutics's dividend yieldView Halozyme Therapeutics's 52-week price rangeView Halozyme Therapeutics's revenue growthView Halozyme Therapeutics's profit marginView Halozyme Therapeutics's debt-to-equity ratioView all Halozyme Therapeutics key metricsReturn to Halozyme Therapeutics profile